Through the DGIbd database, we predicted a total of 49 drugs for the prediction of PCOS with GSTP1 (Fig. 6A), including VITAMIN E, CURCUMIN, and RESVERATROL, suggesting their possible roles as therapeutic candidates warranting further investigation. This evidence concerns the gene GSTP1 and polycystic ovary syndrome.